Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MIT Holding Inc MITD

"MIT Holding Inc provides intravenous therapies to patients at their homes in the United States. Further through its affiliations and contractors, the company prepares intravenous medication for home infusion by the patient, administers intravenous infusions, provides medical management services, the ambulatory center where therapies are administered and sells and rents home medical equipment... see more

GREY:MITD - Post Discussion

MIT Holding Inc > MIT Holding, Inc. (MITD) Offers Patients an Opportunity to R
View:
Post by qualitystocks.net on Feb 25, 2015 5:36pm

MIT Holding, Inc. (MITD) Offers Patients an Opportunity to R

MIT Holding, Inc. (MITD) Offers Patients an Opportunity to Relax in Style
 
With advancements in medicine, technology and quality of life, people are, on average, living much longer these days than they ever have before. In an effort to further improve quality of life for its patients, MIT Holding, Inc. (OTCQB: MITD) partners with hospitals, physicians, facility based providers, pharmaceutical manufacturers and healthcare payers, through its portfolio of services, to provide post-acute care to patients nationwide. In addition to educational programs and in-home treatment options, the company offers unique travel ventures designed to dramatically improve its patients’ quality of life without creating unnecessary medical risk.
 
The MIT Holding’s Medical Sea Cruises program will offer individuals who require dialysis or infusion treatment the opportunity to travel abroad with family and friends without missing out on required medical care. The company’s commitment to the care of its patients is the foundation for its unique travel options. With dedicated and trained medical professionals readily available throughout their vacation, patients can relax in style without unnecessary fear of health-related complications.
 
The company’s travel programs open the door for thousands of patients whose travel may have been highly restricted in the past. According to reports from the Centers for Disease Control and Prevention, an estimated 29.1 million people, or 9.3% of the U.S. population, struggle with diabetes, which accounts for just over 38% of kidney failure cases throughout the country. As a result, nearly 230,000 people of all ages live on chronic dialysis, which can seriously restrict the opportunity for prolonged travel.
 
The company’s mission is to be the leader in medical and technological innovations created to enhance the physical, emotional and aesthetic quality of life of its patients. While MIT Holding continues to serve its patients throughout Georgia and South Carolina with high quality ambulatory care and home infusion services, few programs can compare to the potential to enhance the overall freedom and quality of life of patients presented by the company’s Medical Sea Cruises program.
 
For more information on MIT Holding, visit www.mitholdinginc.com
 
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities